서울대학교 중앙도서관
S-Space 소개
My S-Space
로그인이 필요합니다.
Login

S-Space

Browse

Author

Jump to a point in the index
Or type in a year

  • Sort by
  • In order
  • Results/Page
  • Authors/record

Showing results 1 to 29 of 29

Issue DateTitle / Author(s) / CitationFileAltmetrics
2011-03
Screening of anaplastic lymphoma kinase rearrangement by immunohistochemistry in non-small cell lung cancer: Correlation with fluorescence in situ hybridization
DOI
2011-08
Detection of ALK gene rearrangement in non-small cell lung cancer: A comparison of fluorescence in situ hybridization and chromogenic in situ hybridization with correlation of ALK protein expression
DOI
2012-06
Clinicopathologic implication of ALK rearrangement in surgically resected lung cancer A proposal of diagnostic algorithm for ALK-rearranged adenocarcinoma
DOI
2013-01
Discordance between anaplastic lymphoma kinase status in primary non-small-cell lung cancers and their corresponding metastases
DOI
2013-10
A Comprehensive Comparative Analysis of the Histomorphological Features of ALK-Rearranged Lung Adenocarcinoma Based on Driver Oncogene Mutations: Frequent Expression of Epithelial-Mesenchymal Transition Markers than Other Genotype
DOI
2015-02
A histomorphologic predictive model for axillary lymph node metastasis in preoperative breast cancer core needle biopsy according to intrinsic subtypes
DOI
2015-07
Distinctive role of SIRT1 expression on tumor invasion and metastasis in breast cancer by molecular subtype
DOI
2015-11
Expression of SIRT1 and apoptosis-related proteins is predictive for lymph node metastasis and disease-free survival in luminal A breast cancer
DOI
2016-02
Oncogenic role of SIRT1 associated with tumor invasion, lymph node metastasis, and poor disease-free survival in triple negative breast cancer
DOI
2016-07
Loss of ataxia-telangiectasia-mutated protein expression correlates with poor prognosis but benefits from anthracycline-containing adjuvant chemotherapy in breast cancer
DOI
2017-01
MicroRNA expression profiles and clinicopathological implications in lung adenocarcinoma according to EGFR, KRAS, and ALK status
DOI
2017-01
Clinicopathological categorization of Epstein-Barr virus-positive T/NK-cell lymphoproliferative disease: an analysis of 42 cases with an emphasis on prognostic implications
DOI
2017-09
Clinicopathologic implications of the miR-197/PD-L1 axis in oral squamous cell carcinoma
DOI
2017-11
PD-L1 immunohistochemical assays for assessment of therapeutic strategies involving immune checkpoint inhibitors in non-small cell lung cancer: a comparative study
DOI
2018-03
Osteosarcomatous differentiation in rebiopsy specimens of pulmonary adenocarcinoma with EGFR-TKI resistance

Ahn, Hyein; Kwon, Hyun Jung; Park, Eunhyang; Kim, Hyojin; Chung, Jin-Haeng

Journal of Pathology and Translational Medicine, Vol.52 No.2, pp.130-132

DOI
2018-09
Potential oncogenic role and prognostic implication of microRNA-155-5p in oral squamous cell carcinoma

Kim, Hyojin; Yang, Jeong Mi; Ahn, Soon-Hyun; Jeong, Woo-Jin; Chung, Jin-Haeng; Paik, Jin Ho

Anticancer Research, Vol.38 No.9, pp.5193-5200

DOI
2018-10
Low expression of CD40L in tumor-free lymph node of oral cavity cancer related with poor prognosis

Rah, Yoon Chan; Ahn, Jae-Cheul; Jeon, Eun-Hui; Kim, Hyojin; Paik, Jin Ho; Jeong, Woo-Jin; Kwon, Soon-Young; Ahn, Soon-Hyun

International Journal of Clinical Oncology, Vol.23 No.5, pp.851-859

DOI
2019-05
Prognostic effects of abnormal DNA damage response protein expression in breast cancer
DOI
2019-12
Cluster of Lymphadenitis due to Nontuberculous Mycobacterium in Children and Adolescents 8-15 Years of Age
DOI
2020-06
Estrogen receptor α as a predictive biomarker for survival in human papillomavirus-positive oropharyngeal squamous cell carcinoma
DOI
2022-03
Artificial Intelligence-Powered Analyzer Reduces Inter-observer Variation in PD-L1 Tumor Proportion Score of Non-Small Cell Lung Cancer
2022-04
Comparison of the Predictive Power of a Combination versus Individual Biomarker Testing in Non-Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors
DOI
2022-05
Clinicopathologic and protein markers distinguishing the "polymerase epsilon exonuclease" from the "copy number low" subtype of endometrial cancer

Kim, Kidong; Hwangbo, Suhyun; Kim, Hyojin; Kim, Yong Beom; No, Jae Hong; Suh, Dong Hoon; Park, Taesung

Journal of Gynecologic Oncology, Vol.33 No.3, p. e27

DOI
2022-06
Artificial Intelligence-Powered Spatial Analysis of Tumor-Infiltrating Lymphocytes as Complementary Biomarker for Immune Checkpoint Inhibition in Non-Small-Cell Lung Cancer
DOI
2022-08
Impact of Pediatric Alopecia Areata on Quality of Life of Patients and Their Family Members: A Nationwide Multicenter Questionnaire Study
DOI
2022-08
Identification of differentially expressed microRNAs as potential biomarkers for carcinoma ex pleomorphic adenoma
DOI
2022-09
Landscape of EGFR mutations in lung adenocarcinoma: a single institute experience with comparison of PANAMutyper testing and targeted next-generation sequencing

Lee, Jeonghyo; Han, Yeon Bi; Kwon, Hyun Jung; Lee, Song Kook; Kim, Hyojin; Chung, Jin-Haeng

Journal of Pathology and Translational Medicine, Vol.56 No.5, pp.249-259

DOI
2023-12
PSMD1 as a prognostic marker and potential target in oropharyngeal cancer
view fileDOI
2024-02
Inflamed immune phenotype predicts favorable clinical outcomes of immune checkpoint inhibitor therapy across multiple cancer types
DOI
1